A unified multi‐activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS)
| Autor: | Andrew Hollander, Michael Weaver, Tawfik Giaddui, Curtis Miyamoto, B Micaily, Stephanie E. Weiss, Bin Wang, S Li |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Coefficient of determination
Stereotactic body radiation therapy Cell Survival medicine.medical_treatment Brachytherapy HDR Radiosurgery 030218 nuclear medicine & medical imaging SRS 03 medical and health sciences EQD2 0302 clinical medicine medicine Range (statistics) Lung cancer Cell survival Survival analysis Research Articles Physics SBRT business.industry General Medicine medicine.disease BIOLOGICAL PHYSICS AND RESPONSE PREDICTION Radiobiological Outcome modeling High-Dose Rate Brachytherapy 030220 oncology & carcinogenesis Dose Fractionation Radiation Nuclear medicine business Relative Biological Effectiveness Research Article |
| Zdroj: | Medical Physics |
| ISSN: | 2473-4209 0094-2405 |
| Popis: | PURPOSE Application of linear-quadratic (LQ) model to large fractional dose treatments is inconsistent with observed cell survival curves having a straight portion at high doses. We have proposed a unified multi-activation (UMA) model to fit cell survival curves over the entire dose range that allows us to calculate EQD2 for hypofractionated SBRT, SRT, SRS, and HDRB. METHODS A unified formula of cell survival S=n/eDDo+n-1 using only the extrapolation number of n and the dose slope of Do was derived. Coefficient of determination, R2 , relative residuals, r, and relative experimental errors, e, normalized to survival fraction at each dose point, were calculated to quantify the goodness in modeling of a survival curve. Analytical solutions for α and β, the coefficients respectively describe the linear and quadratic parts of the survival curve, as well as the α/β ratio for the LQ model and EQD2 at any fractional doses were derived for tumor cells undertaking any fractionated radiation therapy. RESULTS Our proposed model fits survival curves of in-vivo and in-vitro tumor cells with R2 > 0.97 and r |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text